Michael David Smith

Insider Reports History

Entity
Individual
Location
C/O Kalvista Pharmaceuticals, Inc., 55 Cambridge Parkway, Suite 901 E, Cambridge, MA
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael David Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KalVista Pharmaceuticals, Inc. Senior VP, Development Restricted Stock Units 15.5K $127K $8.23 May 17, 2022 Direct
KalVista Pharmaceuticals, Inc. Senior VP, Development Employee Stock Option (Right to Buy) 10.3K May 17, 2022 Direct

Insider Reports Filed by Michael David Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALV KalVista Pharmaceuticals, Inc. May 17, 2022 2 $0 4 May 19, 2022 Senior VP, Development
KALV KalVista Pharmaceuticals, Inc. Jun 1, 2021 3 -$138K 4 Jun 3, 2021 Senior VP, Development
KALV KalVista Pharmaceuticals, Inc. May 26, 2021 1 $0 4 May 28, 2021 Senior VP, Development